NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 18 filers reported holding NEPHROS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252,654 | -0.8% | 170,712 | +3.9% | 0.00% | – |
| Q2 2023 | $254,662 | +62.3% | 164,298 | +12.0% | 0.00% | – |
| Q1 2023 | $156,938 | -7.5% | 146,685 | 0.0% | 0.00% | – |
| Q4 2022 | $169,744 | +26.7% | 146,685 | -0.7% | 0.00% | – |
| Q3 2022 | $134,000 | -28.7% | 147,783 | +20.5% | 0.00% | – |
| Q2 2022 | $188,000 | -65.2% | 122,678 | -0.2% | 0.00% | – |
| Q1 2022 | $541,000 | -25.5% | 122,978 | 0.0% | 0.00% | – |
| Q4 2021 | $726,000 | -18.5% | 122,978 | +21.0% | 0.00% | – |
| Q3 2021 | $891,000 | -12.1% | 101,618 | +1.7% | 0.00% | – |
| Q2 2021 | $1,014,000 | +58.4% | 99,936 | +3.9% | 0.00% | – |
| Q1 2021 | $640,000 | +10.7% | 96,195 | +42.6% | 0.00% | – |
| Q4 2020 | $578,000 | +41.0% | 67,439 | +18.9% | 0.00% | – |
| Q3 2020 | $410,000 | -13.9% | 56,737 | 0.0% | 0.00% | – |
| Q2 2020 | $476,000 | +33.3% | 56,737 | 0.0% | 0.00% | – |
| Q1 2020 | $357,000 | – | 56,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,687,438 | $5,457,408 | 1.21% |
| BARD ASSOCIATES INC | 186,039 | $275,338 | 0.11% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,341 | $67 | 0.04% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 71,037 | $106,228 | 0.00% |
| STATE STREET CORP | 15,698 | $23,469 | 0.00% |
| MORGAN STANLEY | 15,292 | $22,632 | 0.00% |
| BLAIR WILLIAM & CO/IL | 36,249 | $53,649 | 0.00% |
| BlackRock Inc. | 4,131 | $6,114 | 0.00% |
| HighTower Advisors, LLC | 56,710 | $83,000 | 0.00% |